Back
State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF Vs. Novo Nordisk A/S Industry Stock Comparison
Buy
54
SPYX
State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF
Last Price:
$56.45
Seasonality Move:
-0.08%
Sell
32
NONOF
Novo Nordisk A/S
Last Price:
$47.97
Seasonality Move:
3.42%
Buy
54
State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF (SPYX)
is a Buy
Is State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF a Buy, Sell or Hold?
-
The current State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF [SPYX] share price is $56.47. The Score for SPYX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
SPYX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Novo Nordisk A/S (NONOF)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NONOF] share price is $47.97. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SPYX Stock Price Chart
What is State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF's stock price today?
-
The State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF share price today is $56.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPYX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $47.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
SPYX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.47 | Buy |
| Relative Strength Index (14 RSI): | 56.56 | Buy |
| Chaikin Money Flow: | 235388 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.96 - 56.56) | Buy |
| Bollinger Bands (100): | (53.2 - 56.02) | Buy |
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 47.32 | Sell |
| Chaikin Money Flow: | 119855 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.7 - 49.04) | Buy |
| Bollinger Bands (100): | (47.98 - 57.06) | Sell |
SPYX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.08 | Buy |
| 20-day SMA: | 56.11 | Buy |
| 50-day SMA: | 55.67 | Buy |
| 200-day SMA: | 51.22 | Buy |
| 8-day EMA: | 35.54 | Buy |
| 20-day EMA: | 18.47 | Buy |
| 50-day EMA: | 8.27 | Buy |
| 200-day EMA: | 2.19 | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 48.77 | Sell |
| 20-day SMA: | 47.97 | Buy |
| 50-day SMA: | 49.79 | Sell |
| 200-day SMA: | 60.54 | Sell |
| 8-day EMA: | 48.26 | Sell |
| 20-day EMA: | 48.36 | Sell |
| 50-day EMA: | 50.04 | Sell |
| 200-day EMA: | 62.85 | Sell |
State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF Earnings Growth & SPYX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
State Street SPDR S&P 500 Fssl Fuel Rsrvs Free ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novo Nordisk A/S Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||